What is Nephrocalcinosis?
Nephrocalcinosis is the deposition of calcium salts (primarily calcium phosphate or calcium oxalate) within the renal parenchyma itself—specifically in the tubular epithelial cells and interstitial tissue—rather than in the urinary collecting system where kidney stones form. 1, 2
Key Distinguishing Features
Nephrocalcinosis must be differentiated from nephrolithiasis (kidney stones):
- Nephrocalcinosis: Calcium deposits within kidney tissue (parenchyma)
- Nephrolithiasis: Calcium deposits within the urinary collecting system and tract 3
This distinction is critical because radiologic imaging (CT, ultrasound) can show calcifications in both conditions, making visual differentiation challenging. Modern endoscopic techniques now allow direct visualization to confirm true tissue calcification versus stones 4.
Clinical Significance and Underlying Mechanisms
Nephrocalcinosis represents a pathologic endpoint of multiple metabolic and genetic disorders rather than a single disease entity. 2, 5 The condition primarily affects the renal medulla (medullary nephrocalcinosis being most common), though cortical and diffuse patterns also occur 3.
The renal medulla is particularly vulnerable due to:
- Hyperosmolality
- Hypoxia
- Slow tubular flow
- Loss of crystallization inhibitors 5
Major Etiologic Categories
In Children:
- Hereditary tubular disorders (most common): distal renal tubular acidosis, Dent disease
- Metabolic disorders: idiopathic hypercalciuria, primary hyperoxaluria
- Iatrogenic causes: vitamin D intoxication, prematurity-related hypercalciuria 3
In Adults:
- Primary hyperparathyroidism (when serum calcium is high or high-normal) 1
- Distal renal tubular acidosis type 1
- Medullary sponge kidney
- Primary hyperoxaluria (urinary oxalate >75 mg/day without bowel dysfunction) 1
Diagnostic Implications
The presence of nephrocalcinosis on imaging implies an underlying metabolic disorder or anatomic condition predisposing to stone formation and places patients at greater risk of recurrence. 1 Over 30 genes have been identified affecting tubular transport, mineral homeostasis, oxalate metabolism, and other pathways 5.
Critical Diagnostic Pitfall:
Non-contrast CT commonly used for stone diagnosis can show calcifications near renal papillae that may actually be stones rather than true nephrocalcinosis. Definitive diagnosis of nephrocalcinosis is essentially an endoscopic diagnosis requiring direct visual inspection of the papillae, not purely a radiologic diagnosis. 4
Clinical Presentations
Pediatric patients typically present with:
- Electrolyte disorders (47%)
- Failure to thrive (50%)
- Sensorineural hearing loss (23%)
- Often detected incidentally 6
Adult patients more commonly present with:
- Associated nephrolithiasis (73%)
- Low back pain (42%)
- Lower estimated GFR
- May have monogenic disease (genetic suspicion in 57.6% of adults) 6
Prognostic Considerations
The underlying cause determines prognosis dramatically:
- Dent disease: Limited supportive therapies, often progresses to early renal replacement
- Renal tubular acidosis: Good renal prognosis with effective treatment 7
Primary hyperoxaluria warrants particular attention as it can lead to early-onset nephrocalcinosis and chronic kidney disease, requiring immediate investigation and early etiological treatment to prevent or delay progression. 3, 7